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Schizophrenia candidate regions 33–51 cM in length on chromosomes 5q, 6q, 10p, and 13q were investigated for
genetic linkage with mapped markers with an average spacing of 5.64 cM. We studied 734 informative multiplex
pedigrees (824 independent affected sibling pairs [ASPs], or 1,003 ASPs when all possible pairs are counted), which
were collected in eight centers. Cases with diagnoses of schizophrenia or schizoaffective disorder (DSM-IIIR criteria)
were considered affected ( ). Data were analyzed with multipoint methods, including nonparametric linkagenp 1,937
(NPL), ASP analysis using the possible-triangle method, and logistic-regression analysis of identity-by-descent (IBD)
sharing in ASPs with sample as a covariate, in a test for intersample heterogeneity and for linkage with allowance
for intersample heterogeneity. The data most supportive for linkage to schizophrenia were from chromosome 6q;
logistic-regression analysis of linkage allowing for intersample heterogeneity produced an empirical P value ! .0002
with, or without, inclusion of the sample that produced the first positive report in this region; the maximumPp .0004
NPL score in this region was 2.47 ( ), the maximum LOD score (MLS) from ASP analysis was 3.10 (empiricalPp .0046
), and there was significant evidence for intersample heterogeneity (empirical ). More-modestPp .0036 Pp .0038
support for linkage was observed for chromosome 10p, with logistic-regression analysis of linkage producing an
empirical and with significant evidence for intersample heterogeneity (empirical ).Pp .045 Pp .0096
Introduction
The present investigators have formed a consortium for
the purpose of combining a set of eight clinical samples
into a large sample of 1800 pedigrees multiply affected
with schizophrenia (MIM 18150, 603175, 603176), for
genetic linkage studies of chromosomal regions in which
positive evidence for linkage has been reported. This
consortium has grown out of three previous efforts. A
report of modestly positive evidence for linkage on chro-
mosome 22q (Pulver et al. 1994b) led to two collabo-
rative studies (Pulver et al. 1994a; Gill et al. 1996) in-
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volving 4 and 11 samples, respectively. The second of
these studies analyzed a combined sample of 436 ASPs
and reported modest support for linkage, with Pp
at D22S278 using likelihood-based ASP analysis..004
Subsequently, 14 research groups studied 15 markers in
regions of chromosomes 3p, 6p, and 8p, in a total of
567 pedigrees (687 independent affected sib pairs)
(Schizophrenia Linkage Collaborative Group for Chro-
mosomes 3, 6, and 8 1996). Suggestive evidence for link-
age was observed for chromosomes 6p ( forPp .0004
* The Schizophrenia Linkage Collaborative Group III includes all au-
thors, who are listed in the following order: study coordinators (Lev-
inson, Holmans), principal investigators of each research group (Straub,
Owen, Wildenauer, Gejman, Pulver, Laurent), and additional authors
from each group, with groups listed according to the number ofpedigrees
contributed. Participating research groups are identified in the paper as
“MCV/Ireland” (Straub, Kendler, Walsh), “U Wales” (Owen, Norton,
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Table 1
Previous Results in Regions Selected for Study
GROUP REFERENCE(S)
NO. OF
PEDIGREES
CHROMOSOMEa
5q 6q 10p 13q
Utah Coon et al. (1994) 9
Kiel Moises et al. (1995) 5
US/Aust Levinson et al. (1998), Martinez et al. (1999) 43 
NIMH SGI:
White Faraone et al. (1998) 43 
Black Kaufman et al. (1998) 30 
White and black Cao et al. (1997), Martinez et al. (1999) 63 
JHU Blouin et al. (1998) 54 
SUNY/AxyS Shaw et al. (1998) 70 
Utah/Palau Coon et al. (1998) (Isolate)
U Wales Williams et al. (1999) 100
MCV/Ireland Straub et al. (1997a) 265  
U Bonn Wildenauer et al. (1997) 72  
U Chicago Cao et al. (1997), Martinez et al. (1999) 53 
a p one of the most positive results in genome scan; p nominal P ! .001; p nominal P ! .00002.
the combined sample, after removing the sam-Pp .001
ple in which the finding was first reported) and 8p
( for the entire sample, with thePp .00018 Pp .0014
original sample removed), but not for chromosome 3p.
These studies may be useful in focusing further attention
on regions that demonstrate evidence for linkage across
multiple data sets. Therefore, further studies of candi-
date regions seem justified.
We report here the results of the first effort of the
Schizophrenia Linkage Collaborative Group III (SLCG
III), which plans to complete at least three further stud-
ies with the same data set. SLCG III studies include the
seven multiplex schizophrenia samples collected by the
participating groups and an eighth data set collected by
the National Institute of Mental Health (NIMH)
Schizophrenia Genetics Initiative (SGI) (Cloninger et al.
1998), which is available through a NIMH-sponsored
repository. Because of expansions of some of the par-
ticipating samples, a larger data set (1800 ASPs) is avail-
able than was available for earlier collaborations, with
a smaller number of participating groups, which facil-
itates coordination of the studies. It is hoped that main-
taining a consistent data set will permit valid compar-
ison of multicenter linkage results in various candidate
regions, without the selection bias that could emerge if
groups participated in some studies and not others. The
genetic analysis strategy has also been modified to in-
clude both analyses of the combined sample and logistic
regression analyses, which take heterogeneity among
samples into account.
Material and Methods
Selection of Regions for Study
The investigators selected the four regions for study
on the basis of published and reported genetic linkage
studies of schizophrenia, attempting to identify the
regions for which there was significant evidence for link-
age in at least one study (i.e., chromosome 13q) or for
which at least two studies reported that the region was
either associated with suggestive evidence for linkage or
produced one of the most significant results in a genome
scan (i.e., chromosomes 5q, 6q, and 10p). Previous stud-
ies of these four regions are summarized in table 1.
Chromosome 5q
The MCV/Ireland group reported a maximum het-
erogeneity LOD score of 3.35 ( ) on chro-Pp .0002
mosome 5q22-q31 at D5S804, under a narrow diag-
nostic model and a recessive genetic model, with an NPL
score of 2.84 ( ) (Straub et al. 1997b). In thePp .002
same region, the U Bonn group simultaneously reported
maximum LOD scores of 1.8 at marker IL9 in 14 ped-
igrees and 1.27 at D5S399 in an additional 40 pedigrees
(Schwab et al. 1997).
Chromosome 6q
The U Chicago group reported a P value of .00018
by ASP analysis at D6S474 in 53 pedigrees containing
61 independent ASPs (Cao et al. 1997). The same group
then typed 87 independent ASPs from the NIMH SGI
sample and observed a P value of .00095 at D6S424,
∼14 cM proximal to the Chicago peak (Cao et al. 1997).
The US/Aust group subsequently studied 43 pedigrees
containing 54 independent ASPs and observed a P value
of .013, also at D6S424 (Martinez et al. 1999).
Chromosome 10p
The most positive result in the NIMH SGI genome
scan of 43 European-American pedigrees was an NPL
score of 3.36 ( ) at D10S1423 (Faraone et al.Pp .0004
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Table 2
SLCG III Samples
CENTER
NO. OF
PEDIGREES
NO. OF ASPS
NO. OF
INDIVIDUALS
Unweighted Weighted
Affected
(Scz/SA) Typed
U Bonn 71 108 88 165 306
U Chicago 63 95 75 159 305
CNRS 48 95 69 144 290
JHU 53 65 51 145 363
MCV/Ireland 216 273 226 618 1,408
US/Aust 65 73 64 202 359
U Wales 148 188 166 327 465
NIMH SGI 70 106 85 177 319
Total 734 1,003 824 1,937 3,815
NOTE.—Shown are the number of informative pedigrees in which
subjects were considered affected with DSM-IIIR schizophrenia and
schizoaffective disorder; the number of ASPs (unweighted) counting
allN# (N1)/2 possible pairs in each sibship, whereNp the number
of affected sibs; the number of ASPs weighted to be equivalent toN1
pairs; the number of individual typed subjects affected with DSM-IIIR
schizophrenia or schizoaffective disorder; and the total number of
typed individuals. References for sample descriptions and ascertain-
ment and for laboratory methods are: U Bonn, Schwab et al. (1998);
U Chicago, Cao et al. (1997); CNRS, Campion et al. (1994) and
Bonnet-Brilhault et al. (1999); JHU, Blouin et al. (1998);MCV/Ireland,
Straub et al. (1995, 1998); US/Aust, Levinson et al. (1998); U Wales,
Williams et al. (1999); and NIMH SGI, Cloninger et al. (1998) and
Kaufmann et al. (1998). The NIMH SGI sample was genotyped for
this study by the US/Aust group.
1998). In precisely the same region, the MCV/Ireland
group (Straub et al. 1998) observed a maximum NPL
score of 1.88 ( ) and a maximum multipoint het-Pp .03
erogeneity LOD score of 1.91 ( ), the fourth-Pp .006
most-positive region in their genome scan, and the U
Bonn group (Schwab et al. 1998) reported an MLS of
2.13 by multipoint ASP analysis and an NPL score of
3.2 ( ).Pp .0007
Chromosome 13q
Lin et al. (1995) reported a heterogeneity LOD score
of 1.61 at D13S144 and later reported (Lin et al. 1997)
a maximum multipoint LOD score of 2.58 near
D13S122 and D13S128 in an expanded European sam-
ple, although the region was negative in East Asian fam-
ilies. Pulver’s group (JHU sample) subsequently reported
a maximum NPL score of 4.18 ( ) in 54 ped-Pp .00002
igrees, near D13S174, 8–10 cM centromeric from the
results of the studies by Lin et al. (Blouin et al. 1998).
Likelihood-based analyses demonstrated a maximum
LOD score of 4.54 with a dominant model. In a repli-
cation data set of 51 families, these authors observed an
NPL score of 2.36 ( ) in the same region. ThePp .007
SUNY/Oxford/AxyS study (Shaw et al. 1998) observed
a maximum NPL score of 1.83 at D13S170, 11 cM
centromeric to the JHU peak. Brzustowicz et al. (1999)
reported a maximum heterogeneity LOD score of 4.42
at D13S793 (about 10 cM distal to the JHU peak) in
21 extended Canadian families.
Clinical Samples
The characteristics of the eight clinical samples are
summarized in table 2. The table also lists references
summarizing the clinical methods of each study. In brief,
only family members with DSM-IIIR diagnoses of
schizophrenia or schizoaffective disorder were consid-
ered affected for this analysis and are counted in table
2. Schizoaffective disorders have been included because
there is substantial evidence that, as they are currently
defined, schizoaffective and schizophrenic disorders co-
segregate in the same families and are quite difficult to
differentiate reliably even by clinicians in the same re-
search program (Faraone et al. 1996) (reviewed by Lev-
inson et al. [1999] and Levinson and Mowry [2000]).
Each data set included pedigrees with two or more cases
of schizophrenia or related disorders, in constellations
that are informative for linkage analysis. All subjects
gave informed consent and were evaluated by trained
research clinicians using a semistructured research di-
agnostic interview schedule and best-estimate diagnosis
on the basis of interviews, available records, and in-
formant reports. A total of 3,815 individuals were gen-
otyped, including 1,937 individuals affected with schizo-
phrenia or schizoaffective disorder and unaffected
relatives such as parents or siblings of probands, from
734 pedigrees containing 824 “independent” ASPs
(number of affected siblings 1) and 1,003 ASPs when
all possible pairs are counted.
Predominant ethnic origins of subjects were: U Bonn,
German (white) and Israeli (Sephardic); U Chicago and
US/Aust, white or black; CNRS, French, and mixed
French-black-Indian-East Asian; JHU, white; MCV/Ire-
land, Irish (all white); UWales, British (all white).Details
are provided in the papers referenced in table 2.
Selection of DNA Markers
Polymorphic markers that had produced high-quality
genotypes in previous studies by participating groups
were selected where possible, supplemented by addi-
tional markers to create maps with a mean spacing of
5.64 cM (SD p 1.73). A total of 32 markers were se-
lected, including 21 dinucleotide repeats and the re-
mainder tri- or tetranucleotide repeats, with mean het-
erozygosity of 0.77. The maps are shown in table 3,
with distances from Marshfield maps.
Genotyping
Each participating group genotyped the selectedmark-
ers in its own sample; the NIMH SGI sample was gen-
otyped at these markers for this study by the US/Aust
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Table 3
Markers Selected for Study of Candidate
Regions
Marker Heterozygosity
Locationa
(cM)
D5S2027 .78 119.5
D5S2055 .84 125.91
D5S818 .78 130.94
D5S2057 .80 135.25
D5S393 .83 140.72
D5S210 .80 147.49
D5S640 .79 152.62
D10S189 .73 19.00
D10S1412 .73 28.31
D10S2325 .85 32.80
D10S191 .82 37.90
D10S1423 .74 46.23
D10S197 .75 52.10
D10S1426 .74 59.03
D10S604 .66 66.50
D10S1220 .62 70.23
D6S445 .69 91.34
D6S1613 .91 97.11
D6S424 .56 104.08
D6S301 .76 111.17
D6S268 .74 114.93
D6S474 .80 118.64
D6S267 .76 121.97
D6S262 .83 130.00
D13S170 .90 63.9
D13S795 .60 71.06
D13S1241 .82 76.26
D13S779 .66 82.93
D13S174 .87 84.87
D13S797 .71 90.27
D13S173 .82 93.52
D13S895 .88 98.82
a On theMarshfield genetic map, except
for D5S818, D10S1423, and D13S797,
whose locations have been extrapolated
from the Southampton maps and from
available data.
group. All laboratories determined marker genotypes
with semiautomated methods using fluorescinated prim-
ers. Allele numbering was standardized by typing of two
CEPH controls in each laboratory. Details of methods
are available in the publications by each group refer-
enced in table 2.
Statistical Analysis
Two types of analyses were utilized (summarized in
Appendix A). One set of analyses was performed after
all pedigrees were combined into a single sample (with
each analysis repeated without the sample in which a
positive finding in a given region was first reported).
These included multipoint ASP analysis using the pos-
sible triangle algorithm (Holmans 1993) and multipoint
NPL analysis (Kruglyak et al. 1996) (Zall or NPL scores),
both by means of the GENEHUNTER 2.0 package. NPL
analysis was used in addition to ASP analysis because
affected relatives other than siblings of probands were
included in most samples, and NPL analysis considers
the entire constellation of affected relatives. Each anal-
ysis was repeated after omitting the sample in which a
positive result was first reported in each region (the
MCV/Ireland sample for chromosome 5q, the UChicago
sample for chromosome 6q, the NIMH SGI sample for
chromosome 10p, and the JHU sample for chromosome
13q). The analysis of all samples was the planned (pri-
mary) analysis, as the investigators have planned a series
of studies using a consistent data set. Analyses were re-
peated without the first positive data set as a way to
examine possible selection bias, a complex issue which
is discussed further below. Note that while a small num-
ber of unaffected individuals were “trimmed” from ped-
igrees by GENEHUNTER, genotypes from all affected
individuals were retained in analyses.
The second set of analyses utilized logistic regression
of IBD allele sharing in ASPs using site as a covariate,
as proposed by Rice (Rice 1997; Dorr et al. 1997). De-
tails of the method are provided in Appendix B. Two
tests were applied to the present data. The first tested
the significance of the difference in sharing proportions
among centers, treating center (site) as a covariate (i.e.,
a test for intersite heterogeneity). The second tested the
overall significance of linkage while allowing for intersite
heterogeneity, by setting the sharing proportion at .50
(the lowest biologically meaningful proportion), for
every sample with an observed proportion !.50, and
then testing for overall deviation from 50% sharing with
site as a covariate.
As an additional secondary analysis, dominant and
recessive multipoint heterogeneity LOD scores were
computed using GENEHUNTER 2.0, with all unaf-
fected individuals coded as “diagnosis unknown,” for
two models, each with maximum penetrance of 0.50 and
no phenocopies, with disease allele frequencies of .005
for the dominant and .10 for the recessive model. Peak
scores were compared with two-point LOD scores for
the flanking markers which were substantially less pos-
itive than the multipoint results (data not shown). These
analyses are provided only to permit consideration of
possible modes of inheritance and to provide readers
with a comparison with the primary “nonparametric”
analyses; therefore no P values have been computed.
P values reported for NPL tests are pointwise values
computed by GENEHUNTER. For the ASP and logistic
regression analyses, P values were determined by cre-
ating 5,000 and 20,000 simulated replicates of the data
set, respectively (using the actual pedigree structures and
maps of each region), under the assumption of random
segregation, and determining the probability of observ-
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Table 4
ASP MLS Results (Unweighted—All Possible Pairs)
A. Overall Results
GROUP
MAXIMUM LOD (LOCATION) FOR CHROMOSOMAL REGION
5q 6q 10p 13q
U Bonn .52 1.72 (97.1 cM) 1.54 (46.2 cM) .33
U Chicago .19 4.10 (117.1 cM) 2.98 (19.0 cM) .04
CNRS .22 0 1.02 (49.7 cM) .32
JHU 1.41 (150.6 cM) .04 0 2.46 (80.3 cM)
MCV/Ireland 2.48 (140.7 cM) .67 .30 .03
NIMH SGI 0 3.94 (102.7 cM) 1.52 (46.2 cM) .11
US/Aust .03 1.44 (106.9 cM) .08 0
U Wales .60 1.29 (114.9 cM) 0 .21
COMBINED MLS .58 (140.7 cM) 3.10 (106.9 cM) .34 .09
Empirical P .0036
B. Results When the Sample with the First Positive Report Is Omitted
Result MCV/Ireland U Chicago NIMH SGI JHU
Combined maximum LOD .11 2.47 (106.9 cM) .12 .026
Empirical P .01
NOTE.—Shown are maximum LOD scores from multipoint affected sibling pair analyses of each chromosomal
region using the possible triangle method (GENEHUNTER 2.0) using all possible pairs in a sibship for each
sample, for all samples combined, and for all samples omitting the sample in which positive findings in a region
were first reported. For MLS values 11, the peak location is shown underlined. P values are the probability of
observing a value at least as large anywhere in the region (segmentwise values) in 5,000 simulated replicates of
the actual sample and map assuming no linkage.
ing each result by chance. Note that these P values are
therefore segment-wise rather than point-wise.
All analyses of IBD sharing in affected sibling pairs
(MLS analyses using combining samples and logistic re-
gression) were carried out first with all possible pairs or
[N # (N1)]/2 pairs per sibship, where N equals the
number of affected siblings, and then with larger sibships
downweighted so that each sibship contributed the
equivalent of N1 “independent” pairs. Downweight-
ing can be excessively conservative (Meunier et al. 1997;
Sham et al. 1997; Holmans 1998), and using all possible
pairs both in analyses and in simulation of P values can
result in increased power; thus, the unweighted analyses
were considered primary, and the analyses with weight-
ing were carried out for comparison. Here, empirical P
values with and without weighting were quite similar.
For most analyses, results are shown using all possible
pairs (tables 4–7). Results in table 7 (logistic regression
analysis of linkage allowing for intersample heteroge-
neity) are shown both weighted and unweighted, to il-
lustrate the similarity.
Power analyses were carried out for samples of 800
independent ASPs, 34% with missing parents and 66%
with two genotyped parents. One-hundred replicates
were generated and analyzed for a 200-cM chromosome
containing a disease locus under a range of dominant
and recessive generating models, with maximum pene-
trance ranging from .08 to .35, disease allele frequency
from .04 to .70, population phenocopy rate from .10 to
.60, and predicted locus-specific relative risk to sibs (lsibs)
from 1.2 to 3.5, and with either 30% or 100% of fam-
ilies linked. With 30% of families linked, the expected
proportion of pairs sharing 0 alleles by descent (z0) in
linked families is 0.25/lsibs, the expected z0 in unlinked
families is 0.25, the expected z0 in all families is the
weighted average of the two, and the expected popu-
lationwide lsibs is 0.25/z0(population) (Risch 1990a,
1990b). Each replicate was analyzed using multipoint
affected sib-pair analysis with GENEHUNTER 2.0, as
described above, and it was determined how frequently
a maximum LOD score was observed which exceeded
an empirically derived threshold for 5% genomewide
significance (3.3).
Results
Affected Sibling Pair Analyses (Combined Sample)
MLS values are shown in table 4 from ASP analyses
of the combined sample of 1,003 possible ASPs (824
ASPs after downweighting) from 734 pedigrees. The
value given for each sample is the maximum value ob-
served throughout the region for that sample analyzed
separately; when the maximum LOD score for a sample
was 11.0, the location, in cM, of the result for that
sample is shown in parentheses. The total MLS shown
is the maximum observed for all samples combined. The
only region with a significant segmentwise P value was
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chromosome 6q, with MLS of 3.10 and P p .0036,
slightly distal to D6S424. Removal of the first reported
positive data set for each region did not change the pat-
tern of results, but the P value for chromosome 6q with-
out the U Chicago data set was more modest (.01). Re-
sults of ASP analyses for the combined sample and for
each sample separately are shown in figure 1.
NPL Analyses
Results of NPL analyses of the combined sample of
734 pedigrees are shown in table 5. As for ASP analyses,
the maximum value for each sample analyzed separately
is shown, and when the pointwise P value for a sample
was !.05, the location is shown in parentheses. The only
region with a significant pointwise P value was chro-
mosome 6q (Z p 2.47, P p .0046). For chromosome
6q, the maximum evidence for linkage in various sam-
ples was observed in a region ∼20 cMwide, and without
the U Chicago data set, the maximum NPL score shifted
slightly toward the centromere. The NPL score was es-
sentially identical with and without the U Chicago data
set, unlike the MLS, which was reduced without the U
Chicago data set. One possible explanation for this is
that some of the more-positive samples included pedi-
grees with affected individuals other than the affected
sibship, and these individuals would contribute to the
NPL score but not to the MLS.
Logistic Regression Analyses
Table 6 shows the IBD sharing probabilities for the
sample from each site and the results of the logistic re-
gression analysis for heterogeneity among samples. Sig-
nificant heterogeneity was observed for chromosome 6q
and for chromosome 10p. Table 7 shows the results of
logistic regression analyses of the significance of linkage,
taking heterogeneity among samples into account. The
results are expressed as LOD scores that are larger than
are customarily observed for a given level of significance
because of the number degrees of freedom (7 for the
primary analysis, 6 with one sample omitted). Chro-
mosome 6q produced evidence for linkage bothwith and
without weighting of larger sibships and with or without
the U Chicago sample. Chromosome 10p produced ev-
idence for linkage when all possible pairs were consid-
ered (unweighted analysis); this evidence was slightly
reduced without the NIMH SGI sample.
Dominant and Recessive LOD Scores
Dominant and recessive LOD scores for the entire
sample are shown in table 8. A maximum LOD score
of 2.47 was observed for chromosome 6q using a re-
cessive model. No other region produced a LOD score
12.0.
Power of Affected Sib-Pair Analyses
Details of power analyses are available on request.
Power was generally well-predicted by the observed z0
which is related to populationwide lsibs as described
above. Power was excellent (0.85) for values of lsibs
of 1.35, and adequate (0.65–0.70) for lsibs equal to
1.3. Thus the present sample has adequate power to
detect significant linkage of schizophrenia to a locus con-
tributing to a 30%–35% increase in risk to siblings of
affected individuals in the population as a whole. Ry-
bicki and Elston (2000) have recently demonstrated that
for multipicative two-locus models, power may depend
also on susceptibility-allele frequency and genotype rel-
ative risk (ratio of penetrances of the susceptibility and
normal genotypes), and can be less than that predicted
by lsibs alone.
Discussion
In a large collaborative sample, suggestive evidence in
support of linkage to schizophrenia was observed on
chromosome 6q. This evidence was consistent across a
series of planned analyses (NPL and ASP analyses and
logistic regression analysis of allele sharing in ASPs al-
lowing for intersample heterogeneity), with or without
the sample in which positive evidence for this region was
first reported. This region is separated by 50 cM from
the region on chromosome 6p in which evidence for
linkage to schizophrenia has also been reported (Straub
et al. 1995; Schwab et al. 1995; Moises et al. 1995;
Schizophrenia Linkage Collaborative Group for Chro-
mosomes 3, 6, and 8 1996), and all available evidence
suggests that there is no overlap between these two can-
didate regions. The maximum evidence for linkage in
different samples is distributed across a 20-cM region,
with the U Chicago and U Wales data sets producing
peaks at 115–117 cM and the other positive data sets
clustering at 97–106 cM. The reason for this discrepancy
is not known, but simulation studies suggest that, for
complex disorders, the location estimates can vary by
10–30 cM across samples if each sample is not very large
(Hauser and Boehnke 1997; Roberts et al. 1999). In
secondary analyses, the most-positive evidence for link-
age was observed under a recessive model; however, we
would suggest caution in drawing conclusions about
mode of inheritance from single-locus analyses of ge-
netically complex disorders.
More modest support for linkage was observed on
chromosome 10p, which was limited to evidence from
the logistic regression analyses of significant intersample
heterogeneity ( ) and excess allele sharing inP ! .001
ASPs allowing for intersample heterogeneity (segment-
wise ).P ! .05
No statistically significant support for linkage was
Fi
gu
re
1
Fo
r
ea
ch
ch
ro
m
os
om
al
re
gi
on
,
m
ax
im
um
L
O
D
sc
or
e
va
lu
es
ar
e
sh
ow
n
fo
r
ea
ch
sa
m
pl
e
an
d
fo
r
th
e
co
m
bi
ne
d
sa
m
pl
e,
fo
r
m
ul
ti
po
in
t
A
SP
an
al
ys
is
us
in
g
th
e
po
ss
ib
le
-t
ri
an
gl
e
m
et
ho
d
(G
E
N
E
H
U
N
T
E
R
2.
0)
.
Levinson et al.: Schizophrenia Multicenter Linkage Study 659
Table 5
NPL Analysis
A. Overall Results
GROUP
NPL SCORE (LOCATION) FOR CHROMOSOMAL REGION
5q 6q 10p 13q
U Bonn .09 2.11 (97.1 cM) 2.13 (46.2 cM) .82
U Chicago 1.36 1.92 (118.6 cM) 2.24 (19.0 cM) .30
CNRS .64 .21 1.41 (37.9 cM) .90
JHU 1.60 .14 .34 3.18 (82.9 cM)
MCV/Ireland 2.44 (130.9 cM) .67 1.09 .06
NIMH SGI .01 3.67 (104.1 cM) 2.39 (46.2 cM) .32
US/Aust .43 1.32 .20 .01
U Wales 1.03 1.11 1.11 .59
TOT NPL .96 2.47 (104.1 cM) 1.01 .19
P .152 .0046 .138 .408
B. Results When the Sample with the First Positive Report Is Omitted
Result MCV/Ireland U Chicago NIMH SGI JHU
Total NPL Score .30 2.51 (104.1 cM) .41 .27
P .0047
NOTE.—Shown are NPL (Zall) scores from multipoint nonparametric linkage analyses of each
chromosomal region (GENEHUNTER 2.0) using all typed individuals in each pedigree, for each
sample, for all samples combined, and for all samples omitting the sample in which positive findings
in a region were first reported. P values are pointwise values as reported by GENEHUNTER. For
NPL values with P ! .05, the peak location is shown underlined.
observed in the other two regions studied. For a ge-
netically complex disorder like schizophrenia, the a
priori probability of detecting linkage cannot be deter-
mined, because the magnitude of the genetic effect at
any one locus is unknown, and there may be undetected
differences among samples—in diagnostic methods, as-
certainment, or other factors—that could obscure evi-
dence for linkage in a collaborative analysis. Thus, link-
age cannot be disproved, and we can only conclude that
the current analyses fail to add to the existing evidence
for linkage on chromosomes 5q and 13q.
The most difficult methodological issue here is pos-
sible selection bias (the inclination of investigators to
study regions in which they already have positive find-
ings). For example, the largest schizophrenia multicen-
ter analysis of marker D22S278 (Gill et al. 1996) was
initiated by several groups with positive evidence at this
marker. While suggestive evidence for linkage (P k
in some analyses) was observed in the entire data.001
set, more modest evidence for linkage ( ) wasP k .05
observed in those samples in which this region had not
been previously genotyped. The next large multicenter
study (Schizophrenia Linkage Collaborative Group for
Chromosomes 3, 6, and 8 1996) included all 11 groups
from the earlier study, specifically to avoid selection
bias, along with 3 new groups. Because positive evi-
dence for linkage had initially been observed for each
region in a single sample, the primary analyses could
be repeated without that sample.
The issue of selection bias in the current study is more
complex. The major safeguard against bias here is that
the investigators agreed to work together to study as
many schizophrenia candidate regions as funding will
permit, without prior knowledge of genome scan data
for most of the samples and without first decidingwhich
regions to study. Thus, over time, our studies should
accurately reflect the evidence for linkage across a series
of candidate regions in this particular large sample (al-
though not necessarily reflecting other available sam-
ples). We are currently funded for three further studies
of several regions each. Although a new genome scan
of the entire sample would give the most complete in-
formation, the expense would be quite large, and such
a study is not immediately feasible. As an alternative,
and to supplement our direct studies of candidate
regions, we are currently participating in an effort to
apply a novel metaanalysis technique (Wise et al. 1999)
to investigate evidence for linkage across all available
schizophrenia genome scans.
One could question whether there is a bias inherent
in selecting these regions ahead of others, in part on the
basis of our own previous data. This could result in a
premature enthusiasm for certain regions, when, in fact,
our future candidate region or metaanalysis studies
could produce more-positive results in other chromo-
somal regions. This issue is illustrated by the history of
the chromosome 6q finding, which produced the most
positive results reported here. Evidence for linkage was
first observed in the U Chicago data set (Cao et al.
1997). Their strategy included replication in the NIMH
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Table 6
Logistic Regression Analysis: IBD Probabilities and P Values for
Intersample Heterogeneity
A. Overall Results
GROUP
IBD PROBABILITY FOR CHROMOSOME REGION
5q 6q 10p 13q
U Bonn .52 .58 .59 .48
U Chicago .48 .59 .54 .49
CNRS .54 .43 .56 .54
JHU .60 .49 .40 .64
MCV/Ireland .61 .51 .52 .48
NIMH SGI .43 .64 .59 .47
US/Aust .46 .62 .44 .46
U Wales .46 .54 .46 .47
Empirical P .066 .0038 .0096 .183
B. Results When the Sample with the
First Positive Report Is Omitted
Result MCV/Ireland U Chicago NIMH SGI JHU
Empirical P .40 .014 .029 .98
NOTE.—Shown are the estimated proportion of alleles shared iden-
tical by descent (IBD probabilities) in each sample, and the segment-
wise P value for heterogeneity among samples in IBD probabilities,
analyzed by logistic regression analysis (see text), for all samples and
then omitting the sample in which positive evidence for linkage was
first reported. P values are based on simulation of 20,000 replicates
using the actual sample and map.
Table 7
Logistic Regression Analysis: LOD Scores for Linkage, Allowing for
Intersample Heterogeneity
A. Overall Results
SCORES FOR CHROMOSOMAL REGION
5q 6q 10p 13q
Unweighted: 2.79 7.14 3.41 2.53
Location 152.6 105.5 46.2 84.9
Empirical P a .091 !.0002 .045 .114
Weighted: 2.29 5.48 2.63 2.50
Location 152.6 105.5 46.2 76.2
Empirical P a .098 .0002 .068 .061
B. Results When the Sample with the
First Positive Report Is Omitted
MCV/Ireland U Chicago NIMH SGI JHU
Unweighted: 1.11 6.08 2.55 .29
Location 152.6 105.5 19.0 84.9
Empirical P a .37 .0004 .074 .90
a On the basis of 20,000 replicates.
SGI data set, which was even more strongly positive
(Cao et al. 1997), and in the US/Aust data set (Levinson
et al. 1998) which was weakly positive (Martinez et al.
1999). All three data sets had already been included in
the present consortium. The present investigators met
in February 1998 to plan the present study, selecting
those chromosomal regions with the most significant
reported nominal P values among regions not yet sub-
jected to multicenter study. The overall magnitude of
the results in the U Chicago, NIMH, and US/Australia
samples convinced us that a large multicenter analysis
was justified, with a sample approximately three times
larger than these three combined. But, by this time, com-
plete or partial genome scan data were also available
for the U Wales, MCV/Ireland, JHU, and U Bonn pro-
jects, none of which had observed highly positive evi-
dence for linkage on chromosome 6q.
Given this sequence of events, we conclude that there
is no bias in the present results, given that the sample
was constituted without prior knowledge of the regions
to be studied or the prior results in these regions. There
may some bias in selecting these regions before other
regions, but the only valid correction for this will be to
study all candidate regions or the entire genome. We
have included one set of secondary analyses that ex-
cludes the first sample in which highly positive results
were reported in that region, which at least gives some
indication of the evidence for linkage in the rest of the
sample. Further “correction” would serve little purpose:
if we excluded all samples for which we had some in-
formation prior to the present study, we would have
only one sample (CNRS) left.
We would suggest that relative, rather than absolute,
magnitude of evidence for linkage be given most weight
in interpreting evidence from this and similar studies.
It is not practical in a large multicenter study to take
all steps to maximize evidence for linkage. For example,
the JHU group observed a much higher maximum NPL
score of 4.18 in their sample using additional markers
to form a denser map (Blouin et al. 1998), compared
with a maximum score of 3.18 when their sample was
analyzed here using a 5-cM map density, which was felt
to represent a reasonable balance between power and
efficiency. Similarly, substantial but more modest evi-
dence for linkage on chromosome 10p was observed
here in the NIMH SGI sample, with the white and black
families combined and with a different map, than was
the case in the published reports for the white pedigrees
from that data set (Faraone et al. 1998).
In conclusion, we have reported additional evidence
in support of linkage to schizophrenia on chromosome
6q and more modest evidence in support of linkage on
chromosome 10p. Multicenter analyses may be one use-
ful factor in guiding the efforts of the field in the search
for schizophrenia susceptibility genes.
Online Databases
A review of available evidence for schizophrenia loci is
found in Online Mendelian Inheritance inMan as SCZD
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Table 8
Dominant and Recessive LOD Scores
CHROMOSOME
DOMINANT RECESSIVE
HLOD aa
Location
(cM) HLOD aa
Location
(cM)
5q .92 .08 135.0 .48 .40 140.7
6q .68 .08 104.1 2.47 .12 101.3
10p 1.17 .08 46.2 .83 .05 52.1
13q .66 .06 73.0 .16 .03 93.5
a a p Maximum-likelihood proportion of linked families.
[MIM 18150]. The chromosome 13q locus studied in
this article is listed as SCZD7 [MIM 603176], and the
chromosome 6q locus studied here is listed as SCZD5
[MIM 603175]. There is no accession number for the
chromosome 10p locus listed here. For chromosome 5q,
the region described as SCZD1 [MIM 181510] is con-
siderably proximal to the region studied here, which
does not have an OMIM accession number.
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Appendix A
Statistical Analysis Plan
A. Planned (primary) analyses
1. Whole sample (pooled)
a. ASP analysis (GH 2.0), unweighted, empirical P
b. NPL analysis
2. Logistic regression of ASP sharing proportions (q)
with sample as covariate
a. Test for heterogeneity (allows different value for
q for each sample)
b. Empirical P value (5,000–20,000 replicates)
B. Additional (secondary) analyses
1. Logistic regression of ASP sharing proportions
a. Test for overall significance of linkage allowing
for heterogeneity (set if actual )qp .5 q ! .5
b. Empirical P value
2. Multipoint parametric analyses using dominant and
recessive affected-only models
Appendix B
Logistic Regression Analysis
Rice’s logistic regression method (Dorr et al. 1997;
Rice 1997) was used to determine, for ASPs, the effect
of site as a covariate in determining allele sharing, and
the overall significance of allele sharing when site effects
are taken into account. The method is as follows: con-
sider a random variable S defined on sib pairs, where
if that pair inherits a marker allele IBD from aSp 1
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particular parent and if the allele inherited by theSp 0
pair from that parent is not IBD. Assume that S has a
logistic regression on a set of covariates X1,…,Xn; that
is,
ps
log p a b1X1 ... bnXn ,( )1 ps
where is the probability of sharing. Note that if apps
b1 p … p bn p 0, then p 1/2 for all covariateps
values; this corresponds to the null hypothesis of no
linkage. For each pair, the probability of sharing 0, 1,
or 2 alleles IBD may be written in terms of the par-
ent-specific IBD probabilities 1, 2 as follows, assum-ps ps
ing that the probabilities of inheriting an allele IBD from
each parent are independent: Pr(0 ibd) p
(1 1)(1 2), Pr(1 ibd) p 1(1 2)  2(1 1),ps ps ps ps ps ps
Pr(2 ibd) p 1 2.ps ps
Multipoint likelihoods can thus be calculated, and hy-
potheses regarding the parameters a, b1,…, bn can be
tested. For example, if only ASPs are analyzed, the al-
ternative hypothesis of overall linkage corresponds to
. The main advantage of this method for the anal-a 1 0
ysis of multicenter data is that it enables differences be-
tween centers to be modeled and tested systematically,
as noted by Rice (1997).
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